ArticleCureus2026
Managing Cardiac Amyloidosis in a Rural Cardiology Practice: Bridging Gaps in Specialized Evaluation and Disease-Modifying Treatment.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac amyloidosis is an underdiagnosed condition characterized by the deposition of amyloid fibrils in the myocardium. Its timely diagnosis remains challenging, particularly in a rural cardiology setting where access to advanced imaging, tissue biopsy, and genetic evaluation is often limited. Early initiation of disease-modifying therapy is critical; however, real-world guidance for clinicians practicing outside tertiary centers is sparse. We describe three consecutive patients diagnosed with cardiac amyloidosis in a rural cardiology clinic, each presenting with non-specific heart failure symptoms that masked classic red-flag features of cardiac amyloidosis. Despite resource constraints, all patients were effectively evaluated using a streamlined diagnostic pathway. Disease-modifying therapy was initiated promptly. This case series demonstrates that early recognition and effective management of cardiac amyloidosis can be achieved in rural settings using a practical and reproducible protocol. We present our experience as a real-world framework to help rural clinicians identify and treat amyloidosis at the earliest opportunity with the aim of improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.